2012 Annual Meeting | Pain Management Basics: A Primer for Neurologists
| 01:00 PM - 01:40 PM |
Understanding Variation in Pain Intensity: The Neurobiological Perspective
Jeffrey S. Mogil, PhD |
|
| 01:40 PM - 01:50 PM |
Questions and Answers
|
|
| 01:50 PM - 02:30 PM |
An Evidence Based Approach to Neuropathic Pain
John T. Farrar, MD |
|
| 02:30 PM - 02:45 PM |
Questions and Answers
|
|
| 02:45 PM - 03:00 PM |
Break
|
|
| 03:00 PM - 03:40 PM |
Measuring Pain and Assessing Analgesic Efficacy
Nathaniel Katz, MD, MS |
|
| 03:40 PM - 04:00 PM |
Questions and Answers
|
|
| 04:00 PM - 04:40 PM |
Case-Based Discussion of Pain Management in Chronic Neuropathic Conditions
John Markman, MD, FAAN |
|
| 04:40 PM - 05:00 PM |
Questions and Answers
|
| John Markman, MD, FAAN | Dr. Markman has received personal compensation for serving as an employee of Eli LIlly. |
| Nathaniel Katz, MD, MS | No disclosure on file |
| John T. Farrar, MD | Dr. Farrar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharma. Dr. Farrar has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for PharamcoEpidemiology and Drug Safety. The institution of Dr. Farrar has received research support from Food and Drug Administration . The institution of Dr. Farrar has received research support from NIH . |
| Jeffrey S. Mogil, PhD | No disclosure on file |